Epigenetic Information Loss and Chronosenescence in Liver Aging: From Molecular Mechanisms to Therapeutic Interventions

May 28, 2026FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Loss of Epigenetic Information and Biological Aging in the Liver: From How It Happens to Possible Treatments

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Liver aging is associated with progressive functional decline and increased susceptibility to metabolic diseases.

Some aspects of liver aging may reflect partially reversible disruptions in regulatory programs rather than solely irreversible damage.
Epigenetic information loss and age-related deterioration of circadian clock robustness are identified as interlinked drivers of liver aging.
The NAD/SIRT1 axis could serve as a central hub connecting epigenetic changes with energy metabolism.
Emerging therapeutic strategies include lifestyle interventions, NAD restoration, chronotherapy, and various reprogramming approaches, though many are still in early stages.
Selected regulatory features of liver aging may be modifiable, but direct causal evidence in humans is limited.

AI simplified

Liver aging involves progressive functional decline and increased susceptibility to metabolic diseases. Emerging evidence supports the view that some aspects of liver aging reflect partially reversible disruption of epigenetic and circadian regulatory programs, rather than exclusively irreversible molecular damage. This review focuses on two interlinked drivers: epigenetic information loss and chronosenescence, defined as age-related deterioration of circadian clock robustness. The NAD/SIRT1 axis is discussed as a central hub connecting these processes with energy metabolism. This comprehensive review synthesizes evidence from foundational studies and recent advances in single-cell multiomics, spatial transcriptomics, and CRISPR epigenetic editing technologies. It also evaluates emerging therapeutic strategies, including lifestyle intervention, NADrestoration, chronotherapy, partial cellular reprogramming, chemical reprogramming, and extracellular vesicle-based approaches, with emphasis on their current translational maturity and limitations. The integrated analysis highlights the spatial heterogeneity of liver aging and supports mechanistic links between epigenetic remodeling, circadian disruption, NADdecline, inflammation, and metabolic dysfunction. Experimental studies suggest that selected regulatory features of liver aging can be modified, but direct causal evidence in humans remains limited, and most rejuvenation-oriented strategies remain preclinical or early translational. This review establishes a unified framework for understanding liver aging as a disorder of regulatory information and temporal coordination. It provides a cautious translational roadmap for identifying modifiable nodes in liver aging while emphasizing that clinical application will require rigorous validation of safety, durability, delivery, patient selection, and long-term outcomes. + + +

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (XML) ↗View full text ↗

Epigenetic Information Loss and Chronosenescence in Liver Aging: From Molecular Mechanisms to Therapeutic Interventions

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief